Grünenthal Group

  • Aussender Logo
  • Grünenthal Group
Grünenthal PRO is joining SHL Medical’s alliance partnership network to offer final assembly service for Molly® autoinjectors

Aachen (OTE) - Grünenthal PRO, the contract development and manufacturing organization (CDMO) division of Grünenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive...

  • 04.09.2025, 10:03:04
  • /
  • OTE0001
  • Aussender Logo
  • Grünenthal Group
Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Aachen, Germany (OTE) - Aachen, Germany (ots)

  • 02.06.2025, 10:00:33
  • /
  • OTE0002
  • Aussender Logo
  • Grünenthal Group
Maren Thurow starts as new Head Global Communications at Grünenthal

Aachen (OTE) - Maren Thurow has today assumed the role of Vice President and Head Global Communications at Grünenthal. She succeeds Florian Dieckmann, who has played a key role in evolving the company’s Communications department...

  • 20.05.2025, 10:36:02
  • /
  • OTE0001
  • Aussender Logo
  • Grünenthal Group
Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

Aachen, Germany & Toronto, Canada, (OTE) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that...

  • 24.02.2025, 15:44:17
  • /
  • OTE0001
  • Aussender Logo
  • Grünenthal Group
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Aachen, Germany (OTE) - Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025.

  • 09.01.2025, 10:27:48
  • /
  • OTE0001
>